I think we are all stating the obvious:- Market requires regular...

I think we are all stating the obvious:

- Market requires regular reporting/news to have credibility - quarterly;
- great we have lots of trials going on which shows third party interest;
-totally understand the need for organizations conducting trials to be independent which supports credibility;
- as GBM agile is now almost 30 months into the trial / no information other the no of patients were not expanded. Does agile not also imply some agility in reporting?
- mgmt needs to be more active when they work with third independent parties, it needs to be stressed at the end of the day investors pay for their work and they need to be accountable to provide regular quarterly reporting whatever the facts at that point in time. I think this is biggest problem here along with the lack of strategic and timely capital raise misses.


With the missed reporting timelines to date market is in wait and see mode as expected. The other obvious is there is no leak in any information with all of these studies which is a good sign in a weird way.

Hoping for some positive news very very soon before we run out of cash again.